These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

561 related items for PubMed ID: 24038660

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Gamma-secretase inhibitors enhance temozolomide treatment of human gliomas by inhibiting neurosphere repopulation and xenograft recurrence.
    Gilbert CA, Daou MC, Moser RP, Ross AH.
    Cancer Res; 2010 Sep 01; 70(17):6870-9. PubMed ID: 20736377
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signature.
    Kristoffersen K, Nedergaard MK, Villingshøj M, Borup R, Broholm H, Kjær A, Poulsen HS, Stockhausen MT.
    Cancer Biol Ther; 2014 Jul 01; 15(7):862-77. PubMed ID: 24755988
    [Abstract] [Full Text] [Related]

  • 24. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
    Hsu EC, Kulp SK, Huang HL, Tu HJ, Salunke SB, Sullivan NJ, Sun D, Wicha MS, Shapiro CL, Chen CS.
    Neoplasia; 2015 Jun 01; 17(6):497-508. PubMed ID: 26152358
    [Abstract] [Full Text] [Related]

  • 25. Blocking the NOTCH pathway can inhibit the growth of CD133-positive A549 cells and sensitize to chemotherapy.
    Liu J, Mao Z, Huang J, Xie S, Liu T, Mao Z.
    Biochem Biophys Res Commun; 2014 Feb 21; 444(4):670-5. PubMed ID: 24502949
    [Abstract] [Full Text] [Related]

  • 26. A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.
    Giachino C, Boulay JL, Ivanek R, Alvarado A, Tostado C, Lugert S, Tchorz J, Coban M, Mariani L, Bettler B, Lathia J, Frank S, Pfister S, Kool M, Taylor V.
    Cancer Cell; 2015 Dec 14; 28(6):730-742. PubMed ID: 26669487
    [Abstract] [Full Text] [Related]

  • 27. A novel triazole, NMK-T-057, induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch signaling.
    Das A, Narayanam MK, Paul S, Mukhnerjee P, Ghosh S, Dastidar DG, Chakrabarty S, Ganguli A, Basu B, Pal M, Chatterji U, Banerjee SK, Karmakar P, Kumar D, Chakrabarti G.
    J Biol Chem; 2019 Apr 26; 294(17):6733-6750. PubMed ID: 30824542
    [Abstract] [Full Text] [Related]

  • 28. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
    Li Y, Wang W, Wang F, Wu Q, Li W, Zhong X, Tian K, Zeng T, Gao L, Liu Y, Li S, Jiang X, Du G, Zhou Y.
    J Mol Cell Biol; 2017 Aug 01; 9(4):302-314. PubMed ID: 28486630
    [Abstract] [Full Text] [Related]

  • 29. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
    López-Valero I, Dávila D, González-Martínez J, Salvador-Tormo N, Lorente M, Saiz-Ladera C, Torres S, Gabicagogeascoa E, Hernández-Tiedra S, García-Taboada E, Mendiburu-Eliçabe M, Rodríguez-Fornés F, Sánchez-Domínguez R, Segovia JC, Sánchez-Gómez P, Matheu A, Sepúlveda JM, Velasco G.
    Theranostics; 2020 Aug 01; 10(11):5120-5136. PubMed ID: 32308772
    [Abstract] [Full Text] [Related]

  • 30. Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells.
    Sarkar S, Mirzaei R, Zemp FJ, Wei W, Senger DL, Robbins SM, Yong VW.
    Cancer Res; 2017 Jun 15; 77(12):3231-3243. PubMed ID: 28416488
    [Abstract] [Full Text] [Related]

  • 31. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y, Cheng Z, Liu J, Torre-Healy L, Lathia JD, Nakano I, Guo Y, Thompson RC, Freeman ML, Wang J.
    Stem Cell Reports; 2017 Dec 12; 9(6):1948-1960. PubMed ID: 29198824
    [Abstract] [Full Text] [Related]

  • 32. PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.
    Wang K, Zhang Q, Li D, Ching K, Zhang C, Zheng X, Ozeck M, Shi S, Li X, Wang H, Rejto P, Christensen J, Olson P.
    Clin Cancer Res; 2015 Mar 15; 21(6):1487-96. PubMed ID: 25564152
    [Abstract] [Full Text] [Related]

  • 33. Glioma initiating cells form a differentiation niche via the induction of extracellular matrices and integrin αV.
    Niibori-Nambu A, Midorikawa U, Mizuguchi S, Hide T, Nagai M, Komohara Y, Nagayama M, Hirayama M, Kobayashi D, Tsubota N, Takezaki T, Makino K, Nakamura H, Takeya M, Kuratsu J, Araki N.
    PLoS One; 2013 Mar 15; 8(5):e59558. PubMed ID: 23704872
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of selective gamma-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design.
    Wei P, Walls M, Qiu M, Ding R, Denlinger RH, Wong A, Tsaparikos K, Jani JP, Hosea N, Sands M, Randolph S, Smeal T.
    Mol Cancer Ther; 2010 Jun 15; 9(6):1618-28. PubMed ID: 20530712
    [Abstract] [Full Text] [Related]

  • 35. Notch signaling contributes to the maintenance of both normal neural stem cells and patient-derived glioma stem cells.
    Hu YY, Zheng MH, Cheng G, Li L, Liang L, Gao F, Wei YN, Fu LA, Han H.
    BMC Cancer; 2011 Feb 22; 11():82. PubMed ID: 21342503
    [Abstract] [Full Text] [Related]

  • 36. Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor Cells.
    Shen Y, Chen H, Zhang J, Chen Y, Wang M, Ma J, Hong L, Liu N, Fan Q, Lu X, Tian Y, Wang A, Dong J, Lan Q, Huang Q.
    PLoS One; 2015 Feb 22; 10(11):e0142594. PubMed ID: 26599017
    [Abstract] [Full Text] [Related]

  • 37. Isoliquiritigenin inhibits the proliferation and induces the differentiation of human glioma stem cells.
    Lin Y, Sun H, Dang Y, Li Z.
    Oncol Rep; 2018 Feb 22; 39(2):687-694. PubMed ID: 29251326
    [Abstract] [Full Text] [Related]

  • 38. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity.
    D'Angelo RC, Ouzounova M, Davis A, Choi D, Tchuenkam SM, Kim G, Luther T, Quraishi AA, Senbabaoglu Y, Conley SJ, Clouthier SG, Hassan KA, Wicha MS, Korkaya H.
    Mol Cancer Ther; 2015 Mar 22; 14(3):779-787. PubMed ID: 25673823
    [Abstract] [Full Text] [Related]

  • 39. Pre-clinical studies of Notch signaling inhibitor RO4929097 in inflammatory breast cancer cells.
    Debeb BG, Cohen EN, Boley K, Freiter EM, Li L, Robertson FM, Reuben JM, Cristofanilli M, Buchholz TA, Woodward WA.
    Breast Cancer Res Treat; 2012 Jul 22; 134(2):495-510. PubMed ID: 22547109
    [Abstract] [Full Text] [Related]

  • 40. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC, Taub JW, Matherly LH.
    Cell Signal; 2014 Jan 22; 26(1):149-61. PubMed ID: 24140475
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 29.